Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
AerovectRx
company
About
Develops pulmonary drug delivery technology.
- 1 - 10
Details
- Last Funding Type
- Seed
- Industries
- Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 1 - 10
- Operating Status
- Active
AerovectRx is an aerosol therapeutic company that develops pulmonary drug delivery technologies for enterprises and individuals. AerovectRx offers AeroCell disposable drug cartridge for inhaled delivery of drugs, vaccines, and therapeutics and It also offers Aerocurrent, a point-of-care therapy system. The company is located in the United States and it was founded in 2005.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.20M
AerovectRx has raised a total of
$1.20M
in funding over 2 rounds. Their latest funding was raised on
Jan 11, 2008 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 11, 2008 | Seed | $1.20M | 2 | — | — | Detail |
| Sep 8, 2006 | Seed | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
AerovectRx is funded by 2 investors.
Emergent Growth Fund
and Georgia Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Emergent Growth Fund
|
— | Seed |
Georgia Venture Partners
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
